Eurofins
This role leads high-impact drug discovery programs from target validation through candidate selection, translating cutting-edge science into clinical-ready compounds. The position involves building and leading cross-functional project teams to design and execute end-to-end discovery strategies for client-driven programs across various therapeutic areas. The ideal candidate will leverage deep scientific expertise and strategic vision to advance compounds into clinical development and IND-enabling stages.
Headquarters
Luxembourg, Luxembourg, Luxembourg
Company Size
10001+ employees
Founded
1987
Eurofins Scientific is a global leader in laboratory testing and contract research, specializing in food, environmental, pharmaceutical product testing and agroscience CRO services. The group comprises more than 1,000 independent companies (over 950 laboratories) across 59 countries with over 65,000 staff and offers more than 200,000 analytical methods. Eurofins provides analytical testing, quality assurance and research services to support product safety, regulatory compliance and R&D. Clients choose Eurofins for its technical expertise, wide methodological coverage and extensive international laboratory network.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eurofins.
Eurofins didn’t post a salary, so this is our estimate from similar listings.
Head of Drug Discovery
Protai
Senior Director, Small Molecule Drug Discovery in Inflammation Discovery
Amgen
Senior/Principal Scientist, Medicinal Chemistry – Peptide Drug Design
SPH Media
VP & Global Head, Discovery Chemistry and DMPK, Oncology Targeted Delivery
AstraZeneca
AI Biologist - Drug Development
DOOR
Senior Scientist, Biologics Drug Discovery
Relation Therapeutics